
Dan Daviau, Canaccord Genuity Group’s chairman and CEO, will spearhead a proposed take-private deal contingent on selling its UK wealth management division. His wholly owned entity, CG Acquisitionco, plans to purchase all remaining shares not already controlled by Daviau or his associates.
Shareholders will receive cash consideration of $7.45 per common share, plus £4.15 per share from expected proceeds of the CGWM UK Sale. The buyer will also acquire all cumulative 5-year rate reset first preferred shares, Series C, for $25.30 per share in cash, plus accrued and unpaid dividends.
The combined consideration is valued at $15.27 per common share, representing a 26.7% premium to the company’s $12.05 TSX closing price on 13 February 2026. This deal is contingent upon the sale of CGWM UK to affiliates of Centerbridge Partners and Mubadala Investment Company, valued at £1.17bn ($1.55bn).
Read Also: UK wealth manager FNZ cuts costs to meet debt obligations
Daviau, alongside certain employees, directors, and shareholders, has agreed to support the transaction, holding or controlling approximately 17.5% of the outstanding common shares. CG Partners Limited Partnership and OstVast Capital Management have also signed voting and support agreements, holding approximately 14.3% of common shares and $12m in convertible debentures.
The agreement includes a 45-day go-shop period ending 30 December 2026, during which Canaccord may seek alternative acquisition proposals. If the take-private transaction does not proceed, Canaccord may use proceeds from the UK wealth sale to reduce net leverage, pursue acquisitions, or invest in the business.
The proposed deal is expected to close in the first half of 2027, subject to shareholder, court, regulatory, and other customary approvals. Canaccord’s UK capital markets operation is not included in the sale and will remain within its global capital markets business.